Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy

Nephrology Dialysis Transplantation

Volumn 14, Issue 11, 1999, Pages 2680-2687

  Lim, Paik Seong ^a,b   Wei, Yau Huei ^c   Yu, York Leng ^b   Kho, Benny ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KUANG TIEN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Erythropoiesis; Erythropoietin therapy; Haemodialysis; Intravenous iron therapy; Oxidative stress; Reactive oxygen species; Uraemia

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALBUMIN; ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; CREATININE; ERYTHROCYTE ENZYME; FERRITIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; HEMOGLOBIN; IRON; IRON SACCHARATE; LACTATE DEHYDROGENASE; LACTIC ACID; LIPID PEROXIDASE; LIPID PEROXIDE; MALONALDEHYDE; POLYUNSATURATED FATTY ACID; PROTEIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; TRANSFERRIN; UNINDEXED DRUG; UREA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IRON METABOLISM; IRON THERAPY; KIDNEY FAILURE; LONG TERM CARE; MAINTENANCE THERAPY; MALE; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; REFERENCE VALUE; UREMIA;

EID: 0033281707     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.11.2680     Document Type: Article

References (40)

1. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis
2. Free oxygen species metabolism during hemodialysis with different membranes
3. Increased lipid peroxidation in patients on maintenance hemodialysis
4. Oxidative stress in haemodialysis
5. Lipoperoxidation in plasma and red blood cells of patients undergoing hemodialysis: Vitamins A, E and iron status
6. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
7. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure
8. Reduced erythrocyte defense mechanisms againts free radical toxicity in patients with chronic renal failure
9. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure
10. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously
11. Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a phase III multicenter clinical trial
12. A randomised controlled study of iron supplementation in patients treated with erythropoietin
13. Reduction of recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
14. Importance of iron supply for erythropoietin therapy
15. Economic appraisal of maintenance parenteral iron administration in treatment of anaemia in chronic haemodialysis patients
16. NKF-DOQI Clinical Practice guidelines for the treatment of anemia of chronic renal failure
17. USA multicenter clinical trial with recombinant human erythropoietin
18. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency
19. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity
20. Studies on the quantitative and qualitative characterization of erythrocytes glutathione peroxidase
21. Glutathione S-transferase: The first enzymatic step in mercapturic acid formation
22. Dynamic state of glutathione in blood plasma
23. Tissue sulfhydryl groups
24. Automated high-performance liquid chromatographic separation with spectrofluorometric detection of a malondialdehyde-thiobarbituric acid adduct in plasma
25. Metal ion-catalyzed oxidation of proteins: Biochemical mechanism and biological consequences
26. The Fenton reagents
27. Lipid peroxidation abnormalities in hemodialyzed patients
28. Lipid peroxidation and antioxidants in continuous ambulatory dialysis patients
29. Superoxide anion generation, erythrocytes superoxide dismutase activity and lipid peroxidation during hemoperfusion and hemodialysis in chronic uremic patients
30. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition, and antioxidant enzymes in continuous ambulatory peritoneal dialysis
31. Antioxidant enzymes and lipoperoxide in blood in uremic children and adolescents
32. Decreased enzymatic protection and increased sensitivity to oxidation damage in erythrocytes as a function of cell and donor age
33. Glutathione peroxidase protein: Absence in selenium deficiency states and correlation with enzymatic activity
34. Correction of selenium deficiency in hemodialyzed patients
35. The role of lipid peroxidation in the toxicity of foreign compounds to liver cells
36. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure
37. Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency
38. Red cells gluthathione content and stability in renal insufficiency
39. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rHuEPO treatment
40. Multicomponent investigations of the hydrogen peroxide- and hydroxyl radical scavenging antioxidant capacities of biofluids: The roles of endogenous pyruvate and lactate